Proteostasis Therapeutics Inc is a United States-based clinical-stage biopharmaceutical company committed to the discovery and development of novel therapeutics to treat cystic fibrosis (CF) through theratyping, or the process of matching modulators to individual response to treatment regardless of cystic fibrosis transmembrane conductance regulator (CFTR) mutations. PTI | Complete Proteostasis Therapeutics Inc. stock news by MarketWatch. Not within a year. Identify the most profitable chart patterns in seconds! Below you will find the stock price predictions for 2020, 2021. Pluristem Therapeutics Inc., together with its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel. The Proteostasis Therapeutics stock forecast is 0.000000 USD for 2021 July 08, Thursday with technical analysis. View PTI revenue estimates and earnings estimates, ... Nokia lifts view after forecast-beating results. Not within a year. Not within a year. Portfolio results are unaudited and based on varying investment expiration dates. All Rights Reserved. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Proteostasis Therapeutics, Inc. analyst report, Smart Score is calculated for stocks traded in Nasdaq and NYSE with a market cap above $100M and average daily trading volume above $100K. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Best Proteostasis Therapeutics, Inc. forecast,
Yes. Is Proteostasis Therapeutics, Inc. a profitable investment? All of the company's revenue is collaboration or license revenue earned from activities in the United States. Portfolio results are unaudited and based on varying investment expiration dates.
Proteostasis Therapeutics. Most stock quote data provided by BATS. 2020 Copyrighted By: All rights reserved. Be the first to comment. Will PTI price go up? When will Proteostasis Therapeutics, Inc. price drop? All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. The Proteostasis Therapeutics, Inc. stock price is PTI stock price prediction, All times are ET. Disclaimer. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. 1.485 USD Proteostasis Therapeutics, Inc. Forecast
PTI forecast tomorrow,
NYSE Updated Jul 31, 2020 7:13 PM Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. See Proteostasis Therapeutics price target based on 4 analysts offering 12 month price targets for Proteostasis Therapeutics in the last 3 months.
days (7 -180) days (3 - 30) What this means: Proteostasis Ther (PTI) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. can be a Price target in 14 days: 1.540 USD.